Literature DB >> 19261860

Dopamine D1 and D2 receptor family contributions to modafinil-induced wakefulness.

Jared W Young1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19261860      PMCID： PMC2697968          DOI： 10.1523/JNEUROSCI.5843-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN： 0270-6474            Impact factor:   6.167


× No keyword cloud information.
  13 in total

1.  Pharmacological profile of antidepressants and related compounds at human monoamine transporters.

Authors:  M Tatsumi; K Groshan; R D Blakely; E Richelson
Journal:  Eur J Pharmacol       Date:  1997-12-11       Impact factor: 4.432

2.  Evidence for the involvement of dopamine receptors in ethanol-induced hyperactivity in mice.

Authors:  C Cohen; G Perrault; D J Sanger
Journal:  Neuropharmacology       Date:  1997-08       Impact factor: 5.250

3.  Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.

Authors:  Bertha K Madras; Zhihua Xie; Zhicheng Lin; Amy Jassen; Helen Panas; Laurie Lynch; Ryan Johnson; Eli Livni; Thomas J Spencer; Ali A Bonab; Gregory M Miller; Alan J Fischman
Journal:  J Pharmacol Exp Ther       Date:  2006-08-02       Impact factor: 4.030

4.  Modafinil binds to the dopamine uptake carrier site with low affinity.

Authors:  E Mignot; S Nishino; C Guilleminault; W C Dement
Journal:  Sleep       Date:  1994-08       Impact factor: 5.849

5.  Dopaminergic role in stimulant-induced wakefulness.

Authors:  J P Wisor; S Nishino; I Sora; G H Uhl; E Mignot; D M Edgar
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

Review 6.  Modafinil: a review of neurochemical actions and effects on cognition.

Authors:  Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2007-08-22       Impact factor: 7.853

7.  Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors.

Authors:  T M Korotkova; B P Klyuch; A A Ponomarenko; J S Lin; H L Haas; O A Sergeeva
Journal:  Neuropharmacology       Date:  2006-10-30       Impact factor: 5.250

8.  Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat.

Authors:  E Ongini; E Bonizzoni; N Ferri; S Milani; M Trampus
Journal:  J Pharmacol Exp Ther       Date:  1993-08       Impact factor: 4.030

9.  Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.

Authors:  S D Dickinson; J Sabeti; G A Larson; K Giardina; M Rubinstein; M A Kelly; D K Grandy; M J Low; G A Gerhardt; N R Zahniser
Journal:  J Neurochem       Date:  1999-01       Impact factor: 5.372

10.  Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity.

Authors:  Diego Centonze; Cristina Grande; Emilia Saulle; Ana B Martin; Paolo Gubellini; Nancy Pavón; Antonio Pisani; Giorgio Bernardi; Rosario Moratalla; Paolo Calabresi
Journal:  J Neurosci       Date:  2003-09-17       Impact factor: 6.167
View more
  4 in total

Review 1.  Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Authors:  Jared W Young; Davide Dulcis
Journal:  Eur J Pharmacol       Date:  2015-03-23       Impact factor: 4.432

2.  Dopamine receptor mediation of the exploratory/hyperactivity effects of modafinil.

Authors:  Jared W Young; Klaas Kooistra; Mark A Geyer
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

3.  Superficial Layer-Specific Histaminergic Modulation of Medial Entorhinal Cortex Required for Spatial Learning.

Authors:  Chao He; Fenlan Luo; Xingshu Chen; Fang Chen; Chao Li; Shuancheng Ren; Qicheng Qiao; Jun Zhang; Luis de Lecea; Dong Gao; Zhian Hu
Journal:  Cereb Cortex       Date:  2015-01-16       Impact factor: 5.357

4.  Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development.

Authors:  Dean T Acheson; Elizabeth W Twamley; Jared W Young
Journal:  Front Neurosci       Date:  2013-06-18       Impact factor: 4.677
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.